
Opinion|Videos|August 12, 2024
Clinical Factors Impacting Immunotherapy Response and Optimizing Patient Selection
A panel of experts on non-small cell lung cancer outline factors that impact how well patients respond to immunotherapy.
Advertisement
Video content above is prompted by the following questions:
- Outside of biomarkers, what clinical factors also lead to immune checkpoint inhibitor therapy underperformance?
- How can patient selection be optimized among those less likely to respond to immune checkpoint inhibitor therapy?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
2
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
3
MM’s Vulnerability to CAR T Was a Happy Surprise: Nikhil C. Munshi, MD
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5

